• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Introduction to 6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine (CAS No. 1202-22-8)

6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine, identified by its Chemical Abstracts Service (CAS) number 1202-22-8, is a significant compound in the field of pharmaceutical and agrochemical research. This heterocyclic organic molecule features a pyrimidine core with chloro and methyl substituents, making it a versatile intermediate in the synthesis of various biologically active agents. The structural attributes of this compound contribute to its utility in developing novel therapeutic agents, particularly in the realm of medicinal chemistry.

The pyrimidine scaffold is a fundamental motif in biochemistry, prominently found in nucleic acids such as DNA and RNA. Derivatives of pyrimidine have been extensively explored for their pharmacological properties, including antiviral, anticancer, and antimicrobial activities. The presence of a chloro group at the 6-position and symmetric dimethylation at the 2- and 4-positions enhances the reactivity and functionalization potential of 6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine, enabling further chemical modifications that can tailor its biological activity.

In recent years, there has been growing interest in the development of tetramethylpyrimidine derivatives due to their enhanced metabolic stability and improved pharmacokinetic profiles. The methylation at the N-atoms not only protects the pyrimidine ring from unwanted degradation but also influences its interactions with biological targets. This compound has been investigated as a precursor in synthesizing kinase inhibitors, which are crucial in targeted cancer therapies. The chloro substituent serves as a handle for further functionalization via nucleophilic substitution reactions, allowing chemists to introduce diverse pharmacophores.

Current research in medicinal chemistry highlights the importance of optimizing small molecule scaffolds to achieve high selectivity and efficacy. 6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine has been employed in the synthesis of novel antiviral agents, where its ability to mimic natural pyrimidines offers a strategic advantage. Studies have demonstrated its role in developing inhibitors that disrupt viral replication by interfering with essential enzymatic pathways. The compound’s structural flexibility allows for modifications that can fine-tune its binding affinity to specific protein targets.

The agrochemical sector has also explored derivatives of this compound for their potential as herbicides or fungicides. The chloro group’s reactivity enables the synthesis of compounds that exhibit potent activity against resistant plant pathogens. Additionally, the tetramethylpyrimidine core contributes to stability under environmental conditions, making it a promising candidate for field applications. Researchers are leveraging computational methods to predict and optimize the biological activity of these derivatives, ensuring that future agrochemical products are both effective and sustainable.

Advances in synthetic methodologies have further expanded the utility of 6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine. Transition-metal-catalyzed cross-coupling reactions have enabled the introduction of aryl or heteroaryl groups at various positions on the pyrimidine ring, expanding its pharmacological spectrum. These techniques have been instrumental in generating libraries of compounds for high-throughput screening (HTS), a critical step in drug discovery pipelines. The compound’s compatibility with modern synthetic tools underscores its importance as a building block in medicinal chemistry.

The safety and regulatory aspects of handling 6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine are also critical considerations. While it is not classified as a hazardous material under standard regulations, proper handling procedures must be followed to ensure worker safety and environmental protection. Storage conditions should minimize exposure to moisture and incompatible substances to prevent degradation or unwanted side reactions.

In conclusion, 6-chloro-N2,N2,N4,N4-tetramethylpyrimidine-2,4-diamine (CAS No. 1202-22-8) is a valuable intermediate with broad applications in pharmaceuticals and agrochemicals. Its unique structural features make it an ideal candidate for further derivatization and exploration in drug discovery efforts. As research continues to uncover new therapeutic targets and synthetic strategies, this compound will likely remain at the forefront of molecular innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)